Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A Sialylated Voltage-Dependent Ca2+ Channel Binds Hemagglutinin and Mediates Influenza A Virus Entry into Mammalian Cells.

Fujioka Y, Nishide S, Ose T, Suzuki T, Kato I, Fukuhara H, Fujioka M, Horiuchi K, Satoh AO, Nepal P, Kashiwagi S, Wang J, Horiguchi M, Sato Y, Paudel S, Nanbo A, Miyazaki T, Hasegawa H, Maenaka K, Ohba Y.

Cell Host Microbe. 2018 Jun 13;23(6):809-818.e5. doi: 10.1016/j.chom.2018.04.015. Epub 2018 May 17.

PMID:
29779930
2.

The C-type Lectin Langerin Functions as a Receptor for Attachment and Infectious Entry of Influenza A Virus.

Ng WC, Londrigan SL, Nasr N, Cunningham AL, Turville S, Brooks AG, Reading PC.

J Virol. 2015 Oct 14;90(1):206-21. doi: 10.1128/JVI.01447-15. Print 2016 Jan 1.

3.

Influenza A virus entry into cells lacking sialylated N-glycans.

de Vries E, de Vries RP, Wienholts MJ, Floris CE, Jacobs MS, van den Heuvel A, Rottier PJ, de Haan CA.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7457-62. doi: 10.1073/pnas.1200987109. Epub 2012 Apr 23.

4.

Cell Entry of Influenza A Viruses: Sweet Talk between HA and CaV1.2.

Hoffmann M, Pöhlmann S.

Cell Host Microbe. 2018 Jun 13;23(6):697-699. doi: 10.1016/j.chom.2018.05.019.

PMID:
29902433
5.

Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.

Xia C, Wolf JJ, Vijayan M, Studstill CJ, Ma W, Hahm B.

J Virol. 2018 Mar 14;92(7). pii: e00006-18. doi: 10.1128/JVI.00006-18. Print 2018 Apr 1.

6.

Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.

Xia C, Vijayan M, Pritzl CJ, Fuchs SY, McDermott AB, Hahm B.

J Virol. 2015 Dec 16;90(5):2403-17. doi: 10.1128/JVI.02749-15.

7.

The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus.

Ng WC, Liong S, Tate MD, Irimura T, Denda-Nagai K, Brooks AG, Londrigan SL, Reading PC.

J Virol. 2014 Feb;88(3):1659-72. doi: 10.1128/JVI.02014-13. Epub 2013 Nov 20.

8.

Influenza A virus binding to human neutrophils and cross-linking requirements for activation.

Daigneault DE, Hartshorn KL, Liou LS, Abbruzzi GM, White MR, Oh SK, Tauber AI.

Blood. 1992 Dec 15;80(12):3227-34.

9.

[Function of glycochains in virus infection].

Takahashi T.

Yakugaku Zasshi. 2014;134(8):889-99. Japanese.

10.

Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase.

Cohen M, Zhang XQ, Senaati HP, Chen HW, Varki NM, Schooley RT, Gagneux P.

Virol J. 2013 Nov 22;10:321. doi: 10.1186/1743-422X-10-321.

11.

Functional analysis of glyco-molecules that bind with influenza virus.

Takahashi T.

Uirusu. 2016;66(1):101-116. doi: 10.2222/jsv.66.101. Review. Japanese.

12.

The role of fusion activity of influenza A viruses in their biological properties.

Jakubcová L, Hollý J, Varečková E.

Acta Virol. 2016 Jun;60(2):121-35. Review.

PMID:
27265461
13.

Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses.

Kido H, Okumura Y, Takahashi E, Pan HY, Wang S, Chida J, Le TQ, Yano M.

J Mol Genet Med. 2008 Nov 29;3(1):167-75.

14.

Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Londrigan SL, Short KR, Ma J, Gillespie L, Rockman SP, Brooks AG, Reading PC.

J Virol. 2015 Dec;89(24):12319-29. doi: 10.1128/JVI.01455-15. Epub 2015 Sep 30.

15.

Residue Y161 of influenza virus hemagglutinin is involved in viral recognition of sialylated complexes from different hosts.

Wang M, Tscherne DM, McCullough C, Caffrey M, García-Sastre A, Rong L.

J Virol. 2012 Apr;86(8):4455-62. doi: 10.1128/JVI.07187-11. Epub 2012 Feb 1.

16.

Influenza A virus hemagglutinin and neuraminidase act as novel motile machinery.

Sakai T, Nishimura SI, Naito T, Saito M.

Sci Rep. 2017 Mar 27;7:45043. doi: 10.1038/srep45043.

17.

Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

Job ER, Bottazzi B, Gilbertson B, Edenborough KM, Brown LE, Mantovani A, Brooks AG, Reading PC.

PLoS One. 2013;8(3):e59623. doi: 10.1371/journal.pone.0059623. Epub 2013 Mar 27.

18.

Influenza A virus entry inhibitors targeting the hemagglutinin.

Yang J, Li M, Shen X, Liu S.

Viruses. 2013 Jan 22;5(1):352-73. doi: 10.3390/v5010352. Review.

19.

Kinetic analysis of the influenza A virus HA/NA balance reveals contribution of NA to virus-receptor binding and NA-dependent rolling on receptor-containing surfaces.

Guo H, Rabouw H, Slomp A, Dai M, van der Vegt F, van Lent JWM, McBride R, Paulson JC, de Groot RJ, van Kuppeveld FJM, de Vries E, de Haan CAM.

PLoS Pathog. 2018 Aug 13;14(8):e1007233. doi: 10.1371/journal.ppat.1007233. eCollection 2018 Aug.

20.

Mutations during the Adaptation of H9N2 Avian Influenza Virus to the Respiratory Epithelium of Pigs Enhance Sialic Acid Binding Activity and Virulence in Mice.

Yang W, Punyadarsaniya D, Lambertz RL, Lee DC, Liang CH, Höper D, Leist SR, Hernández-Cáceres A, Stech J, Beer M, Wu CY, Wong CH, Schughart K, Meng F, Herrler G.

J Virol. 2017 Mar 29;91(8). pii: e02125-16. doi: 10.1128/JVI.02125-16. Print 2017 Apr 15.

Supplemental Content

Support Center